Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Heron Therapeutics (HRTX) Shares Issued (2016 - 2025)

Heron Therapeutics' Shares Issued history spans 14 years, with the latest figure at $266000.0 for Q4 2025.

  • For Q4 2025, Shares Issued fell 42.42% year-over-year to $266000.0; the TTM value through Dec 2025 reached $728000.0, up 402.07%, while the annual FY2025 figure was $853000.0, 33.91% up from the prior year.
  • Shares Issued reached $266000.0 in Q4 2025 per HRTX's latest filing, down from $462000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $74.4 million in Q3 2022 to a low of -$73.7 million in Q4 2022.
  • Average Shares Issued over 5 years is $354500.0, with a median of $536000.0 recorded in 2021.
  • Peak YoY movement for Shares Issued: skyrocketed 29333.33% in 2021, then tumbled 12185.08% in 2022.
  • A 5-year view of Shares Issued shows it stood at $610000.0 in 2021, then crashed by 12185.08% to -$73.7 million in 2022, then soared by 99.05% to -$703000.0 in 2023, then skyrocketed by 165.72% to $462000.0 in 2024, then crashed by 42.42% to $266000.0 in 2025.
  • Per Business Quant, the three most recent readings for HRTX's Shares Issued are $266000.0 (Q4 2025), $462000.0 (Q4 2024), and -$703000.0 (Q4 2023).